Handelsman D J
Andrology Unit, Royal Prince Alfred Hospital, Sydney, NSW.
Aust N Z J Med. 1995 Dec;25(6):808-16. doi: 10.1111/j.1445-5994.1995.tb02885.x.
During the second half of the 20th century, progress in developing novel, practical contraceptive methods for men has lagged significantly behind developments for women. Despite the lack of reliable, reversible methods, men throughout the world continue to be strongly involved in family planning but a greater involvement will require more attractive and reliable contraceptive options for men. The closest to fruition are hormonal methods the features of which are reviewed. Landmark WHO contraceptive efficacy studies have established that hormonally-induced azoospermia provides highly effective and reversible contraception for at least 12 months with minimal short-term side effects. Even among the small subgroup of men who remain oligozoospermic during hormonal suppression, good contraceptive efficacy is achieved. The present goals are to develop improved second generation hormonal regimens which provide more uniform azoospermia to obviate the need for monitoring of sperm output and to develop long-acting depot testosterone formulations used alone or with additional gonadotrophin suppressive agents such as progestins or GnRH antagonists. Significant obstacles to progress are the flight of industry from contraceptive R&D dur to the financial deterrent posed by the product liability crisis as well as the low priority accorded male reproductive health. Together those will determine whether the range of contraceptive options available to our children in the 21st century will improve, or whether the historically recent unbalanced increase in reliance on women for family planning will continue.
在20世纪后半叶,男性新型实用避孕方法的研发进展明显落后于女性。尽管缺乏可靠、可逆的方法,但世界各地的男性仍积极参与计划生育,然而若要进一步提高参与度,则需要为男性提供更具吸引力且可靠的避孕选择。最接近成功的是激素避孕法,本文将对其特点进行综述。世界卫生组织具有里程碑意义的避孕效果研究表明,激素诱导的无精子症可提供高效且可逆的避孕效果,持续至少12个月,短期副作用极小。即使在激素抑制期间仍存在少精子症的一小部分男性中,也能实现良好的避孕效果。当前的目标是开发改良的第二代激素方案,以实现更均匀的无精子症,从而无需监测精子生成量,并开发长效储库型睾酮制剂,可单独使用或与其他促性腺激素抑制药物(如孕激素或GnRH拮抗剂)联合使用。进展的重大障碍包括制药行业因产品责任危机带来的经济阻碍而撤离避孕研发领域,以及男性生殖健康的优先级较低。这些因素共同决定了21世纪我们的后代可获得的避孕选择范围是会增加,还是会延续近期在计划生育方面对女性依赖的不平衡增长态势。